Friday, October 29, 2010
Patrick Berquin, M.D., Ph.D., Service de Neuropédiatrie, Centre Hospitalier Universitaire - Université de Picardie Jules Verne, Amiens, France
Rodrigo Escobar, M.D., Medical, Eli Lilly and Company, Madrid, Spain
Esther Cardo Jalon, M.D., Laboratorio de Neurociencias, Hospital Son Llàtzer, Palma de Mallorca, Balearic island, Spain
Marina Danckaerts, M.D., Ph.D., Department of Neurosciences, Katholieke Universiteit, Leuven, Belgium
Kanasagabai Puvanendran, F.R.C.P., M.B.B.S., Child Development Centre, Basildon, Essex, United Kingdom
Katrien De Bruyckere, M.D., Medical Dept., Eli Lilly and Company, Benelux, Brussels, Belgium
Alonso Montoya, M.D., Eli Lilly and Company, Spain, Alcobendas, Spain
Deborah Quail, B.S., European Medical Information Sciences, Eli Lilly and Company, UK, Windlesham, Surrey, United Kingdom
Joaquin Fuentes, M.D., Child and Adolescent Psychiatry Unit, Policlinica Gipuzkoa, San Sebastian, Spain